Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests

Jie Hong; Yi-fei Zhang; Wei-qiong Gu; Yu-wen Zhang; Yu-xia Su; Zhen-ni Chi; Wei-qing Wang; Xiao-ying Li; Guang Ning
December 2008
Endocrine (1355008X);Dec2008, Vol. 34 Issue 1-3, p75
Academic Journal
Abstract  The purpose of this study was to investigate insulin sensitivity and first-phase insulin secretion in obesity with hyperglycemia in 30 and/or 60 min during oral glucose tolerance (OGTT, glucose ≥ 11.1 mmol/l, post-loading hyperglycemia, PLH) in Chinese population. A total of 196 nondiabetic subjects were included in the present study, among them 99 had normal glucose tolerance (NGT, subdivided into 32 lean NGT and 67 obese NGT), 74 had obesity with impaired glucose tolerance (IGT) and 23 had obesity with PLH. A standard 75-g oral glucose tolerance test was performed after fasting and at 30 min, 1, 2 and 3 h. Insulin sensitivity index (S I) was assessed by the Bergman’s minimal model method with frequently sampled intravenous glucose tolerance test (FSIGTT), insulin secretion was determined by acute insulin response to glucose (AIRg). The disposition index (DI), the product of AIRg and S I was used to determine whether AIRg was adequate to compensate for insulin resistance. S I was significantly equally lower in three obese subgroups. AIRg was significantly increased in obese NGT as compared with lean NGT controls, and reduced to the same extent in IGT and PLH subjects. There was no significant difference among lean NGT, IGT and PLH subjects. DI value was reduced from obese NGT individuals, IGT and PLH subjects had a similar lower level of DI. In conclusion, our present results demonstrated that the pathophysiological basis of obese subjects with PLH were clearly insulin resistance and defective in first-phase insulin secretion as that in IGT subjects in Chinese population.


Related Articles

  • One-hour postload plasma glucose levels is associated with the production of hydrogen peroxide in abdominal obese men with normal glucose tolerance. Wang, Rui; Yin, Fu-Zai; Qin, Chun-Mei; Liu, Bo; Ma, Chun-Ming; Lu, Qiang // International Journal of Diabetes in Developing Countries;Mar2013, Vol. 33 Issue 1, p29 

    To study the effects of acute hyperglycemia on oxidative stress during an oral glucose tolerance test (OGTT). This case-control study was conducted on 21 abdominal obese men (waist circumference ≥90 cm) and 21 normal-weight men (waist circumference <90 cm) aged 20~50 years with normal...

  • Diagnosis of Hyperglycemia in a Cohort of Brazilian Subjects. Oliveira, Carolina S.V.; Vieira, José Gilberto H.; Ghiringhello, Maria Teresa; Hauache, Omar M.; Oliveira, Cláudia Helena M.; Khawali, Cristina; Ferrer, Claúdia; Tachibana, Teresinha T.; Maciel, Rui M.B.; Velho, Gilberto; Reis, André F. // Diabetes Care;Aug2007, Vol. 30 Issue 8, p2135 

    The article focuses on a study on insulin sensitivity and insulin secretion profiles in the different stages of hyperglycemia. The study involved 900 subjects who were administered with an oral glucose tolerance test (OGTT). Results showed that insulin sensitivity was lower among subjects with...

  • Opportunistic random blood glucose best.  // Pulse;4/7/2003, Vol. 63 Issue 14, p18 

    Reports that opportunistic random glucose testing for type 2 diabetes in obese patients is more worthwhile than fasting measurements, according o research in Tayside, Scotland, where diagnosed cases have soared by over 50% in five years.

  • Insulin Hypersecretion & Accelerated Insulin Clearance Characterize People With Impaired Fasting Glucose. Perreault, Leigh; Bergman, Bryan C.; Koehler, Mary C.; Eckel, Robert H. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA382 

    By definition, people with isolated impaired fasting glucose (IFG) have mild fasting hyperglycemia, but achieve euglycemia 2 hours after an oral glucose tolerance test (2h OGTT). Why insulin secretion is able to overcome OGTT-induced, but not fasting, hyperglycemia is not clear. The objective of...

  • MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice. Bhattacharjee, Alpana; Allister, Emma M.; Wheeler, Michael B. // Canadian Journal of Physiology & Pharmacology;May2012, Vol. 90 Issue 5, p663 

    Dipeptidyl peptidase-4 (DPP-4) inhibitors increase circulating levels of incretin hormones, which can enhance insulin secretion and β cell function. The aim of this study was to evaluate the effectiveness of MK-626 (a novel DPP-4 inhibitor) to reduce the hyperglycemia and hyperinsulinemia of...

  • Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. Getty, Lisa; Hamilton-Wessler, Marianthe; Ader, Marilyn; Dea, Melvin K.; Bergman, Richard N.; Getty, L; Hamilton-Wessler, M; Ader, M; Dea, M K; Bergman, R N // Diabetes;Dec1998, Vol. 47 Issue 12, p1941 

    We examined the hindlimb lymph insulin profile during simulated intravenous glucose tolerance tests (IVGTTs) in anesthetized dogs to test the following hypotheses: 1) the biphasic insulin response to intravenous glucose can be seen as a priming bolus and a secondary infusion that effect a rapid...

  • Type II diabetes of early onset: a distinct clinical and genetic syndrome? O'Rahilly, S.; Spivey, R.S.; Holman, R.R.; Nugent, Z.; Clark, A.; Turner, R.C. // British Medical Journal (Clinical Research Edition);4/11/1987, Vol. 294 Issue 6577, p923 

    Examines glucose tolerance and insulin secretion in families of patients with type II diabetes in Great Britain. Prevalence of glucose intolerance in patients and siblings; Details of diabetic patients at 25-40 years of age; Reduction of C peptide responses.

  • Postprandial hyperglycemia after a gastrectomy and the prediabetic state: A comparison between a distal and total gastrectomy. Hiroshi Yamamoto; Hiroshi Tsuchihashi; Hiroya Akabori; Hiroyuki Naitoh; Hiroshi Maegawa; Tohru Tani // Surgery Today;Aug2008, Vol. 38 Issue 8, p685 

    Abstract Purpose  Postprandial hyperglycemia is recognized as an important risk factor for developing type 2 diabetes; it is also common in patients after a gastrectomy and is likely to become exacerbated after a total gastrectomy rather than after a distal gastrectomy. In this study, we...

  • Improved Splanchnic Glucose Metabolism Is Responsible for Glycemic Control in T2DM Subjects Treated with Exenatide. Cervera, Antonio; Wajcberg, Estela; Triplitt, Curtis; Fernandez, Marianella; Zuo, Pengo; Defronzo, Ralph A.; Cersosimo, Eugenio // Diabetes;Jun2007 Supplement 1, Vol. 56, pA404 

    Exenatide (EXE) therapy attenuates postprandial hyperglycemia and causes a modest reduction in fasting glucose. To examine the mechanisms behind these effects 6 T2DM subjects (45±8y; BMI=314.2 kg/m², FPG=171±18 mg/dl, HbA[sub 1c]=8.1±0.8%) received a mixed meal tolerance test (MMTT)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics